Bumper Crop of New Drugs Fails to Lift Big Pharma R & D Returns Bumper Crop of New Drugs Fails to Lift Big Pharma R & D Returns

It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news
More News: Health | Pharmaceuticals